Should I buy Aptiv (APTV) stock or is it too late?

Aptiv · Consumer Discretionary · price $44

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 68% of its targets hit on this sector (485 calls tested). It aims for $57 (+29 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).

The 9 reliable analysts $61+38 %

The 3 other firms $75+70 %

How to read it: the 9 reliable firms are not filtered by optimism — 9 aim above the price, 0 below, hence their $61 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Aptiv

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Piper Sandler	33 %	+19.7 %	6	$103 +133%
UBS	60 %	+13.3 %	5	$57 +29%
Morgan Stanley	55 %	+8.0 %	29	$55 +24%
Goldman Sachs	29 %	+3.7 %	7	$61 +38%
JP Morgan	30 %	+3.7 %	10	$56 +27%
Wells Fargo	62 %	+3.4 %	16	$66 +49%
Deutsche Bank	33 %	+1.8 %	9	$75 +69%
Guggenheim	45 %	-5.3 %	11	$64 +45%

In short — Should you invest in Aptiv? Is it too late, still worth it? Analysts are overwhelmingly positive (83% buy, median target $68, i.e. +54%), and the most reliable on APTV targets even higher. But the valuation is stretched (P/E ~43), the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

83% of analysts rate it a buy (Buy consensus, 12 ratings) — a sign of market conviction.
Median price target $68, i.e. +54% from the current price ($44).
The most reliable firm on APTV, Evercore ISI Group (67% hit rate, 3 scored calls), targets $70 (call made on August 10, 2026, maturing on August 10, 2027) (+58%) in its most recent call.
7 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 12 ratings, 2 are neutral.
High valuation (P/E ~43): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on APTV

Median target $68 (+54%) · 12 ratings · Buy consensus

Strong Buy00%

Buy1083%

Hold217%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Aptiv now?

We won't decide for you. The facts: 83% of analysts rate it a buy, median target $68 (+54%), and Evercore ISI Group (most reliable on APTV, 67%) targets $70. Weigh that against valuation (P/E ~43) and volatility. This is not personalized advice.

Is it too late to invest in Aptiv?

Not according to analysts: the median target ($68) is still +54% above the current price ($44) (most reliable on APTV: Evercore ISI Group, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Aptiv still worth investing in?

It depends on the gap between the price ($44) and its estimated value: analysts target $68 on median (+54%), with 83% buys (most reliable on APTV: Evercore ISI Group, 67%). Cross-check with their real reliability on APTV and the cautions above. Information, not advice.

What's the main risk in buying APTV?

The consensus is not unanimous: of 12 ratings, 2 are neutral.

→ Go deeper: the full Aptiv profile (consensus, analyst reliability, price target, performance).